NR2F1 and neoplasm: Investigation of the clinical characteristics of the 73 patients with NSCLC revealed that an elevated NR2F1-AS1 expression was evidently associated with tumor size (P = 0.005), tumor–node–metastasis (TNM) stage (P = 0.038), and lymph node metastasis (P = 0.025), which are indicative of poor prognostic outcomes (Table 1).